Education
About Us
Working with TipRanks
Follow Us
VEA - ETF AI Analysis
Top Page
Vanguard FTSE Developed Markets ETF (VEA)
Rating:61Neutral
Price Target:―
Positive Factors
Very Low Expense Ratio
The fund charges a very low fee, which helps investors keep more of their returns over time.
Broad Country Diversification
Holdings spread across many developed markets like Japan, the UK, Europe, and others reduce reliance on any single country.
Large Asset Base and Recent Positive Performance
The ETF manages a very large pool of assets and has shown steady gains over the past month, three months, and year to date, suggesting healthy investor interest and momentum.
Negative Factors
Sector Tilt Toward Financials and Industrials
A relatively heavy weighting in financial and industrial companies means the fund may be more affected if these sectors struggle.
Mixed Results Among Top Holdings
While some leading positions like ASML and Toyota have performed strongly, others such as Nestlé, SAP, and Royal Bank of Canada have been weaker, which can drag on overall returns.
Limited U.S. Market Exposure
The ETF focuses mainly on non-U.S. developed markets, so investors relying on it alone may miss out on periods when U.S. stocks are leading global performance.
VEA vs. SPDR S&P 500 ETF (SPY)
AUM214.36B
RegionDeveloped Markets
Expense Ratio0.03%
Beta0.72
IssuerVanguard
Inception DateJul 20, 2007
Dividend Yield2.93%
Asset ClassEquity
Index TrackedFTSE Developed ex US All Cap Net Tax (US RIC) Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume21,447,291
30 Day Avg. Volume18,921,995
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
77.21Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering3338
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VEA Summary
Vanguard FTSE Developed Markets ETF (VEA) is a fund that tracks the FTSE Developed All Cap ex US Index, giving you broad exposure to stocks in developed countries outside the United States, such as Japan, the UK, and Europe. It owns hundreds of companies across many sectors, including well-known names like Nestlé, Toyota, and ASML. Someone might invest in VEA to diversify beyond the U.S. and spread risk across many international markets at a low cost. A key risk is that international stock prices can go up and down with global markets and currency swings.
How much will it cost me?The Vanguard FTSE Developed Markets ETF (VEA) has an expense ratio of 0.03%, meaning you’ll pay $0.30 per year for every $1,000 invested. This is much lower than average because it’s a passively managed fund that tracks an index, keeping costs minimal.
What would affect this ETF?The Vanguard FTSE Developed Markets ETF (VEA) could benefit from economic growth in developed markets outside North America, particularly if sectors like financials, technology, and healthcare continue to perform well. However, challenges such as rising interest rates, geopolitical tensions, or regulatory changes in key regions like Europe and Asia could negatively impact its holdings and overall performance.
VEA Top 10 Holdings
VEA leans heavily on overseas blue chips, with Europe and Asia doing most of the talking. ASML is the clear engine here, rising on strong chip demand and giving the fund a tech-powered tailwind. Big pharma names like Roche and Novartis are also pulling their weight, keeping health care a steady contributor. On the flip side, Nestlé and SAP have been lagging, acting like a small anchor on returns. Financial giants such as HSBC and Royal Bank of Canada add a stabilizing, income-oriented backbone to this broadly diversified ex-U.S. mix.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.47% | $4.01B | €450.67B | 61.10% | 76 Outperform | |
| Roche Holding AG | 1.00% | $2.74B | CHF287.79B | 42.71% | 73 Outperform | |
| AstraZeneca | 0.96% | $2.62B | £231.12B | 29.12% | 80 Outperform | |
| HSBC Holdings | 0.94% | $2.55B | £217.54B | 42.42% | 80 Outperform | |
| Novartis AG | 0.92% | $2.50B | CHF235.62B | 31.22% | 80 Outperform | |
| Nestlé SA | 0.87% | $2.37B | CHF200.67B | 13.36% | 71 Outperform | |
| SAP SE | 0.87% | $2.36B | €193.22B | -38.11% | 66 Neutral | |
| Royal Bank Of Canada | 0.84% | $2.28B | $237.03B | 42.26% | 75 Outperform | |
| Toyota Motor | 0.79% | $2.16B | ¥48.29T | 34.78% | 80 Outperform | |
| Shell (UK) | 0.74% | $2.01B | £163.31B | 7.42% | 73 Outperform |
VEA Technical Analysis
Positive
―
Price Trends
64.26
Positive
61.93
Positive
58.74
Positive
Market Momentum
1.27
Negative
68.87
Neutral
84.50
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VEA, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 66.76, equal to the 50-day MA of 64.26, and equal to the 200-day MA of 58.74, indicating a bullish trend. The MACD of 1.27 indicates Negative momentum. The RSI at 68.87 is Neutral, neither overbought nor oversold. The STOCH value of 84.50 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VEA.
VEA Peer Comparison
Comparison Results
Performance Comparison
VEA
Vanguard FTSE Developed Markets ETF
68.76
18.64
37.19%
SCHF
Schwab International Equity ETF
―
―
―
SPDW
SPDR Portfolio Developed World ex-US ETF
―
―
―
IDEV
iShares Core MSCI International Developed Markets ETF
―
―
―
DFAI
Dimensional International Core Equity Market ETF
―
―
―
AVDE
Avantis International Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents